Current Research and Scholarly Interests
I am involved with clinical research related to cancer survivorship, with a particular focus on late effects of childhood cancer treatments and community partnerships to improve health equity for adolescent/young adult cancer survivors in under-resourced settings.
Areas of focus include:
Late effects of novel therapies:
This research relates to the use of BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), as little is known about the long-term and late effects of these therapies in young people. I lead the New Agents task force for the Children's Oncology Group Long-Term Follow-Up Guidelines.
Community partnerships to improve health equity for AYA cancer survivors:
This is a new area of research for me that involves developing community partnerships to translate evidence-based survivorship research to real-world clinical practice settings in communities with socioeconomic disadvantages and structural barriers to long-term follow-up care. This research will target social determinants of health with the goal of improving access to care and health equity. I plan to utilize community-based participatory research methods to understand the key issues facing AYA cancer survivors and to collaboratively develop multi-level pragmatic interventions to improve health equity and access to survivorship care for AYA cancer survivors in communities with socioeconomic disadvantages.
Collaboration between oncology-survivorship-primary care:
In collaboration with a multidisciplinary team, I contributed to the development of an online continuing medical education cancer survivorship course for primary care physicians and other healthcare providers, which is available here: https://mededucation.stanford.edu/courses/health-after-cancer/
We are now in the process of adapting this course for cancer survivors and caregivers.
Adolescent/young adult cancer survivorship care:
As a collaboration with the Stanford Adolescent/Young Adult Cancer (SAYAC) program, I see patients in a pilot clinic for young adult survivors of childhood leukemia and bone marrow transplant, with a focus on cancer survivorship and transitioning to adult-focused care and from active cancer treatment to long-term follow-up care.
